2-63492856-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_015910.7(WDPCP):c.160G>A(p.Asp54Asn) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000234 in 1,612,850 control chromosomes in the GnomAD database, with no homozygous occurrence. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000099 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00025 ( 0 hom. )
Consequence
WDPCP
NM_015910.7 missense, splice_region
NM_015910.7 missense, splice_region
Scores
5
7
7
Splicing: ADA: 1.000
2
Clinical Significance
Conservation
PhyloP100: 5.69
Genes affected
WDPCP (HGNC:28027): (WD repeat containing planar cell polarity effector) This gene encodes a cytoplasmic WD40 repeat protein. A similar gene in frogs encodes a planar cell polarity protein that plays a critical role in collective cell movement and ciliogenesis by mediating septin localization. Mutations in this gene are associated with Bardet-Biedl syndrome 15 and may also play a role in Meckel-Gruber syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WDPCP | NM_015910.7 | c.160G>A | p.Asp54Asn | missense_variant, splice_region_variant | 2/18 | ENST00000272321.12 | NP_056994.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WDPCP | ENST00000272321.12 | c.160G>A | p.Asp54Asn | missense_variant, splice_region_variant | 2/18 | 1 | NM_015910.7 | ENSP00000272321.7 |
Frequencies
GnomAD3 genomes AF: 0.0000988 AC: 15AN: 151824Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
15
AN:
151824
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000133 AC: 33AN: 248530Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 135026
GnomAD3 exomes
AF:
AC:
33
AN:
248530
Hom.:
AF XY:
AC XY:
18
AN XY:
135026
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000248 AC: 362AN: 1461026Hom.: 0 Cov.: 30 AF XY: 0.000238 AC XY: 173AN XY: 726806
GnomAD4 exome
AF:
AC:
362
AN:
1461026
Hom.:
Cov.:
30
AF XY:
AC XY:
173
AN XY:
726806
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000988 AC: 15AN: 151824Hom.: 0 Cov.: 31 AF XY: 0.0000405 AC XY: 3AN XY: 74142
GnomAD4 genome
AF:
AC:
15
AN:
151824
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
74142
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
7
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:5
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Heart defect - tongue hamartoma - polysyndactyly syndrome Pathogenic:2Uncertain:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Dec 21, 2023 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with congenital heart defects, hamartomas of tongue, and polysyndactyly (MIM#217085). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from aspartic acid to asparagine. Additionally, this variant affects the last nucleotide of exon 2, and is predicted to disrupt RNA splicing. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v2: 36 heterozygotes, 0 homozygotes). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. Although this variant has been reported as a variant of uncertain significance by clinical laboratories in ClinVar it has also been reported in three unrelated compound heterozygous individuals with a consistent ciliopathy phenotype (PMID: 33046855, PMID: 27158779, PMID: 25427950). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1010 - Functional evidence for this variant is inconclusive. Reduction of protein expression has been shown in Xenopus embryos, however the functional assay was not quantitative so it was deemed to be insufficient evidence to determine the effect on the protein (PMID: 27158779). (I) 1206 - This variant has been shown to be paternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2015 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Mar 25, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 01, 2017 | This variant was found once in our laboratory In trans with a frameshift variant (C185fs) in a 2-year-old female with mild global delays, aortic coarctation, polydactyly, sublingual cysts. This patient has since been reported (PMID:25427950). Heterozygotes would be expected to be asymptomatic carriers. - |
Orofaciodigital syndrome Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | May 09, 2016 | - - |
WDPCP-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 05, 2024 | The WDPCP c.160G>A variant is predicted to result in the amino acid substitution p.Asp54Asn. This variant is the last nucleotide of exon 2 and is predicted to alter splicing based on available splicing prediction programs (SpliceAI, Jaganathan et al. 2019. PubMed ID: 30661751). This variant has been reported in the compound heterozygous state in two individuals who presented with polydactyly, tongue hamartomas, and/or coarctation of the aorta (Saari et al. 2015. PubMed ID: 25427950; Toriyama et al. 2016. PubMed ID: 27158779). It has also been reported as heterozygous in an individual with obesity and BMI between 35.00 and 39.99 (Savas et al. 2019. PubMed ID: 31216558). This variant is reported in 0.023% of alleles in individuals of Latino descent in gnomAD. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Bardet-Biedl syndrome 15 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 12, 2017 | The WDPCP c.160G>A (p.Asp54Asn) variant has been reported in two studies and found in two patients with ciliopathy phenotypes in a compound heterozygous state with truncating variants and in two unaffected family members in a heterozygous state (Saari et al. 2015; Toriyama et al. 2016). Control data are unavailable for this variant, which is reported at a frequency of 0.00008 in the European (non-Finnish) population of the Exome Aggregation Consortium. Expression of a WDPCP construct with the p.Asp54Asn variant in Xenopus embryos demonstrated reduced protein expression compared to wild type protein, indicating that the variant may disrupt protein stability (Toriyama et al. 2016). Based on the evidence, the p.Asp54Asn variant is classified as a variant of unknown significance but suspicous for pathogenicty for Bardet-Biedl syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Bardet-Biedl syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 06, 2022 | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 54 of the WDPCP protein (p.Asp54Asn). This variant also falls at the last nucleotide of exon 2, which is part of the consensus splice site for this exon. This variant is present in population databases (rs200322968, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of WDPCP-related conditions (PMID: 25427950, 28289185). ClinVar contains an entry for this variant (Variation ID: 162669). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on WDPCP function (PMID: 27158779). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;D
REVEL
Pathogenic
Sift
Benign
D;D;D
Sift4G
Pathogenic
D;D;.
Polyphen
D;D;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 0
Find out detailed SpliceAI scores and Pangolin per-transcript scores at